DNAPrint Genomics, Inc.
OTC: DNAG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jatin Patel
- Employees
- 24
- Headquarters
- Sarasota, United States
- IPO year
- 2001
- Market cap
- $12.9K
- Website
- http://www.dnaprint.com
Loading DNAG…
Loading profile data…Frequently asked questions about DNAG
What does DNAPrint Genomics, Inc. (DNAG) do?
DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an indiv...
Where does DNAG trade?
DNAPrint Genomics, Inc. (DNAG) trades on the Other OTC.
What sector is DNAG in?
DNAPrint Genomics, Inc. (DNAG) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of DNAPrint Genomics, Inc.?
Jatin Patel is the chief executive officer of DNAPrint Genomics, Inc. (DNAG).
Where is DNAPrint Genomics, Inc. headquartered?
DNAPrint Genomics, Inc. is headquartered in United States.
Does DNAG pay a dividend?
DNAPrint Genomics, Inc. (DNAG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DNAG go public?
DNAPrint Genomics, Inc. (DNAG) completed its initial public offering in 2001.